Synoia to Launch New BTX, Collagen and Hyaluronic Infusions for the Revolutionary WISHPro System at CosmoProf Asia, HK 2012
TEL AVIV, Israel, November 13, 2012
TEL AVIV, Israel, November 13, 2012 /PRNewswire/ --
Additional activities include demonstrating WISHPro® and its immediate Anti- Aging and Rejuvenation results.
Synoia Technologies, the fastest growing medical aesthetics devices manufacturer, is excited to announce the launch of 3 new infusion capsules for the WishPro® system, best known for its ability to deliver immediate anti-aging and rejuvenation results.
At CosmoProf Asia, taking place November 14-16, Synoia will introduce 3 new infusion treatments for WISHPro® at booth 3E-K4D.
The new BTX infusion with Acetyl hexapeptide-8 (Argireline®) is specially engineered as a topical treatment that mimics the effects of BOTOX® in the skin without any side effects.
The new Collagen Infusion protects the skin and fights free radicals to slow down skin aging and cell degradation. The infusion contains a special kind of Beta carotene which is significantly stronger in antioxidant activity and repairs DNA.
The third innovative infusion launched contains Hyaluronic Acid that stimulates Collagen and Elastin syntheses, and increases the skins capacity to hold water keeping the skin nourished, moist and healthy.
The new infusions to be launched are designed for WishPro®, the revolutionary aesthetics device launched last year that has become famous for its ability to deliver instant visible results and significantly reduce fine lines and wrinkles in just 15 minutes.
WISHPro® comes with 4 different technology heads cleverly fitting the ideal and proven technological solution to any skin problem.
2 world patents and an innovative business model enabling immediate ROI have made WISHPro® a very popular device for upgrading any salon or spa.
The ability of Synoia to always develop new technology heads and introduce new infusion capsules like the ones currently introduced have positioned Synoia as one of the leading aesthetic devices companies.
Mrs. Ayelet Mofar, Synoia's CEO: "We are proud to have based Synoia in the frontier of latest advanced aesthetic technologies and we will continue to launch new technology heads for WISHPro® that work in unison with the treatment capsules to provide excellent results"
With over 18 years of combined experience in developing innovative medical devices, Synoia's founders have lead the company to the frontier of advanced aesthetic technologies.
Synoia's guiding principal is to offer Aesthetic Practitioners innovative solutions that are 100% safe, effective and profitable.
Synoia's launch of the revolutionary WISHPro® has positioned Synoia as one of the leading companies in the world due to its state of the art technology, world patents, innovative thinking and unique business model. Visit http://www.synoiatech.com